secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001005286-24-000033
Event type: other
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore files FY23 10-K with restatements for FY21-22; corrects inventory and interest errors
--------------------------------------------------------------------------------

- Filed FY23 Annual Report on Form 10-K with SEC on March 20, 2024, restating FY22, FY21, and multiple quarterly periods.
- Restatements correct errors in capitalized interest, inventory valuation (write-downs to net realizable value), and excess/obsolete reserves.
- Lifecore segment adjustments include gross-up of revenues for principal arrangements and accounts receivable reserve for a specific customer.
- Curation Foods segment restatements involve non-current other receivables and reclassification of operating costs between continuing and discontinued ops.
- Company furnished supplementary summary of select financial data on its website to assist investor analysis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000033/0001005286-24-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000033/lndc-20240320.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer